Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

426–450 of 8579

SevereFDA (Drugs)·D-1477-2022·2022-09-14
Milk of Magnesia USP Recalled for Microbial Contamination Nationwide
Plastikon Healthcare LLC is recalling Milk of Magnesia USP due to microbial contamination in non-sterile products. Lot 20074A, distributed nationwide for institutional use, should not be used.
Product
MILK OF MAGNESIA USP, 2400 mg/10 mL, Magnesium Hydroxide, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-6840-72.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1479-2022·2022-09-14
Antacid Oral Suspension Recalled Nationwide for Microbial Contamination
Plastikon Healthcare LLC is recalling an antacid oral suspension distributed nationwide due to microbial contamination. Affected lots 20051A (exp. Aug. 2022) and 20088A (exp. Sep. 2022) should not be used.
Product
Magnesium Hydroxide 2400 mg, Aluminum Hydroxide 2400 mg, Simethicone 240 mg MAX, per 30 mL Oral Suspension, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1342-2022·2022-08-24
Hand sanitizer recalled for methanol contamination and insufficient ethanol
Medek LLC is recalling M Hand Sanitizer due to FDA analysis finding methanol contamination and ethanol levels below label claims. Approximately 256 bottles distributed in Texas.
Product
M Hand Sanitizer Ethyl Alcohol Antiseptic 80%v/v, Topical Solution 128 oz/3,785 mL, Made in Mexico by: Grupo Plast-Y-Kosas S.A. de C.V. Puebla 105 Col. Rodriguez Reynosa, Tam, Mexico C.P. 88630, NDC Code: 77797-001-01, Distributed by: Medek, LLC 315 E. Business Hwy 83 Alamo, TX
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1333-2022·2022-08-10
SANGTER Energy Supplement Capsules Recalled for Undisclosed Sildenafil
Distributor RFR, LLC is recalling SANGTER Energy Supplement Capsules because FDA analysis found they contain undisclosed sildenafil without FDA approval. The product was distributed nationwide and internationally.
Product
SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1350-2022·2022-08-10
SUSTANGO supplement capsules recalled for undisclosed tadalafil content
SUSTANGO capsules contain the undisclosed pharmaceutical ingredient tadalafil and were marketed without FDA approval. Approximately 750 cartons were distributed nationwide via Amazon.
Product
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1292-2022·2022-08-03
Insulin Glargine Prefilled Pens Recalled for Missing Label
Mylan Pharmaceuticals is recalling Insulin Glargine prefilled pens (lot BF21002895) distributed nationwide because some pens lack labels, which could prevent patients from properly identifying and administering the medication.
Product
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specia
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1301-2022·2022-08-03
Propofol Injectable Emulsion Vials Recalled for Particulate Matter Contamination
Pfizer is recalling 54,000 vials of Propofol Injectable Emulsion (Lot DX9067) due to presence of particulate matter identified as a beetle. No illnesses or injuries have been reported.
Product
PROPOFOL — PROPOFOL (PROPOFOL)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1286-2022·2022-08-03
Nifedipine WSP Ointment Recalled Due to Potency Variability
Valor Compounding Pharmacy is recalling Nifedipine WSP 0.2% Ointment due to potency variability. Some batches may be subpotent or superpotent, affecting safety and efficacy.
Product
Nifedipine WSP 0.2% Ointment, 60 gram tubes, Rx only, Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1297-2022·2022-07-27
Artri King Herbal Supplement Tablets Recalled Nationwide for Undeclared Medication
Amazon is recalling Artri King herbal supplement tablets nationwide due to FDA laboratory findings of undeclared diclofenac, a pharmaceutical medication not listed on the label. The product was marketed without FDA approval.
Product
Artri King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B084KSV12L, UPC 7 501031 111190
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1338-2022·2022-07-27
Launch Sequence Aphrodisia Capsules recalled for undeclared tadalafil
Launch Sequence Aphrodisia Capsules contain undeclared tadalafil, making them an unapproved drug. The recall involves 500 4-count tins distributed nationwide in the USA and Canada.
Product
Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1337-2022·2022-07-27
FDA Recalls Launch Sequence Euphoria Capsules for Undeclared Tadalafil
Launch Sequence Euphoria Capsules have been recalled because the product contains undeclared tadalafil, an unapproved active ingredient. The capsules were distributed nationwide in the USA and Canada.
Product
Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1336-2022·2022-07-27
Dietary supplement found to contain undeclared pharmaceutical drug tadalafil
Launch Sequence Capsules dietary supplement recalled for containing undeclared tadalafil, an FDA-approved pharmaceutical ingredient. The product was marketed without required drug approval.
Product
Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS, UPC Code 641378938375.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1295-2022·2022-07-27
Artri Ajo King Tablets Recalled Due to Undeclared Diclofenac
The FDA is recalling Artri Ajo King tablets nationwide after finding they contain undeclared diclofenac, a prescription anti-inflammatory drug. Affected bottles (lot LTARTKNGOMG30220, expiring December 2025) were sold on Amazon.
Product
Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B092P4615M, UPC 7 501031 111190
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1296-2022·2022-07-27
Ortiga mas Ajo Rey supplement recalled for undeclared diclofenac
FDA recalls Ortiga mas Ajo Rey dietary supplement sold nationwide due to undeclared diclofenac. Product marketed as supplement contains pharmaceutical ingredient not listed on label.
Product
Ortiga mas Ajo Rey Reforzado con Omega 3, 6 y 9, is packaged in a carton containing 30 tablets (500 mg c/u) in a bottle and 60 capsules (400 mg c/u) in a bottle, Hecho en Mexico por: Omega Nutrition , Jorge Washington No. 108 Col. Las Americas, Hidalgo del Parral, Chihuahua. C.P
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1188-2022·2022-07-20
Morphine Sulfate Extended-Release Tablets Recalled for Strength Label Mix-up
Bryant Ranch Prepack has recalled Morphine Sulfate extended-release tablets due to a label mix-up where bottles may contain the wrong strength. Contact your pharmacy to verify your correct dose.
Product
Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1187-2022·2022-07-20
Morphine Sulfate Tablets Recalled for Label Mix-up Dosage Error
Morphine Sulfate extended-release tablets (30 mg) distributed in Alabama were recalled due to a critical label mix-up where bottles labeled as 60 mg contain 30 mg, and bottles labeled as 30 mg may contain 60 mg.
Product
Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1284-2022·2022-07-20
Arti King tablets recalled for undeclared pharmaceutical ingredients
Arti King Refozado con Ortiga y Omega 3 Tablets are recalled nationwide because FDA testing found undeclared diclofenac and dexamethasone. The product was marketed without FDA approval and should not be used.
Product
Arti King Refozado con Ortiga y Omega 3 Tablets, 100-count bottles, Hecho en Mexico por: "PLANTAS MEDICINALES DE MEXICO", Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800 Mexico, UPC 7 501031 111138
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1175-2022·2022-07-13
CVS Health Magnesium Citrate Laxative Recalled for Bacterial Contamination
CVS Health Magnesium Citrate SALINE LAXATIVE Oral Solution (1.745 g, Lemon Flavor, 10 FL OZ) is being recalled due to microbial contamination with Gluconacetobacter Liquefaciens. Approximately 98,958 bottles distributed nationwide are affected.
Product
CVS Health Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Lemon Flavor, 10 FL OZ (296 mL), Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 30594 2.
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1160-2022·2022-07-06
Nasal Swab Remedy for Kids Recalled for Microbial Contamination
Allergy Bee Gone for Kids Nasal Swab Remedy is recalled due to FDA-confirmed microbial contamination including yeast, mold, and Bacillus cereus. Affected consumers should stop using the product.
Product
Allergy Bee Gone for Kids Nasal Swab Remedy 0.33 FL OZ (10 mL) tubes, UPC Code 860002022116
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-1166-2022·2022-07-06
Tegsedi Injection Recalled for Higher-Than-Labeled Content
Akcea Therapeutics recalls certain Tegsedi (inotersen) Injection lots due to higher-than-labeled active ingredient content. Affected lots were distributed in Kentucky.
Product
Tegsedi (inotersen) Injection 284 mg/1.5 mL, Rx Only, Sterile solution for Subcutaneous Use, 4 prefilled syringes, each containing 284 mg of inotersen, (equivalent to 300 mg inotersen sodium in 1.5 ml of solution), Distributed by Sobi, Inc. Inc Waltham MA 02451, NDC: 72126-007-01
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1165-2022·2022-07-06
SnoreStop NasoSpray nasal spray recalled for bacterial contamination
SnoreStop NasoSpray nasal spray has been recalled due to bacterial contamination. FDA analysis identified Providencia rettgeri in the product.
Product
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1157-2022·2022-06-22
Artri King Tablets Recalled Due to Undeclared Diclofenac
Artri King Reforzado con Ortiga Omega 3 Tablets are being recalled for containing undeclared diclofenac and being marketed without FDA approval. The recall affects 1,308 bottles distributed nationwide.
Product
Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1167-2022·2022-06-15
Tacrolimus Compounded Suspension Recalled Due to Subpotency
Valor Compounding Pharmacy recalls compounded Tacrolimus 0.5 mg/mL suspension due to subpotency. The medication, distributed in California, may not provide adequate therapeutic levels for immunosuppression in transplant patients.
Product
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-1168-2022·2022-06-15
FDA Recalls Compounded Tacrolimus Suspension Due to Subpotency
Valor Compounding Pharmacy issued a Class I recall for compounded Tacrolimus suspension (Lot 04272022@35) distributed in California due to subpotency.
Product
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Category
Drug
Distribution
1 state
SevereFDA (Drugs)·D-0992-2022·2022-06-08
Anagrelide Capsules Recalled Due to Failed Dissolution Specifications
Teva Pharmaceuticals is recalling Anagrelide Capsules USP 0.5 mg nationwide due to failed dissolution specifications discovered during stability testing. The recall involves lot GD01090 (expired May 2022).
Product
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

426–450 of 8579